Consensus Zynex, Inc.

Equities

ZYXI

US98986M1036

Delayed Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
12.37 USD -1.67% Intraday chart for Zynex, Inc. -3.89% +13.59%

Evolution of the average Target Price on Zynex, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c4fe6e8.pqnfjJzDUtsO-7LU3xZK7CfjoKBOz8irGxcxpQE3OHM._5mowsOSa5B7noaOlkx4oUbW8eIZt7DAIyRFlmt0VADxzL258as8rVGu9w~56e262b5f7d82ea944aead4dbe99d126
RBC Raises Price Target on Zynex to $15 From $13, Keeps Outperform Rating MT
RBC Initiates Zynex at Outperform With $13 Price Target, Cites 'Favorable' Financial Profile, 'Attractive Risk-Reward' MT
Ladenburg Thalmann Adjusts Price Target on Zynex to $28 From $27, Maintains Buy Rating MT
Piper Sandler Upgrades Zynex to Overweight From Neutral, Adjusts Price Target to $18 From $10 MT
B. Riley Raises Zynex's Price Target to $12.50 From $11, Notes Solid Q3 Execution with Momentum Expected Into Q4; Keeps Buy Rating MT
HC Wainwright Lifts Price Target on Zynex to $21 From $20, Maintains Buy Rating MT
Piper Sandler Adjusts Price Target on Zynex to $10 From $7, Maintains Neutral Rating MT
B. Riley Lifts Zynex's Price Target to $11 from $10, Notes 'Solid' Q2 Results with Momentum Expected to Continue in H2; Keeps Buy Rating MT
B. Riley Lowers Zynex's Price Target to $10 from $15.50, Reiterates Buy Rating MT
HC Wainwright Lowers Zynex's Price Target to $20 From $22, Maintains Buy Rating MT
Piper Sandler Adjusts Price Target on Zynex to $7 From $13, Maintains Neutral Rating MT
B. Riley Lowers Zynex's PT to $15.50 from $19.50, Updates Model to Account for Dividends, Krestel Labs Acquisition; Keeps Buy Rating MT
ZYNEX : HC Wainwright Adjusts Price Target on Zynex to $22 From $25, Reiterates Buy Rating MT
ZYNEX : B. Riley Upgrades Zynex to Buy from Neutral on Q2 Order Growth, Increased EBITDA Guide; Raises PT to $19.50 from $19 MT
ZYNEX : Northland Securities Upgrades Zynex to Outperform From Market Perform, Sets $22.50 Price Target MT
ZYNEX : B. Riley Downgrades Zynex to Neutral from Buy on Deteriorating Profitability, Increased Uncertainty; Lowers Price Target to $19 from $23 MT
ZYNEX : Piper Sandler Downgrades Zynex to Neutral From Overweight, Adjusts Price Target to $20 From $28 MT
ZYNEX : Northland Downgrades Zynex to Market Perform From Outperform, Maintains Price Target at $22.50 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
12.37 USD
Average target price
18.98 USD
Spread / Average Target
+53.44%
High Price Target
27 USD
Spread / Highest target
+118.27%
Low Price Target
15 USD
Spread / Lowest Target
+21.26%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Zynex, Inc.

RBC Capital Markets
Ladenburg Thalmann
Piper Sandler
HC Wainwright
B. Riley
Northland Securities
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings